NCT01803477View on ClinicalTrials.gov

Safety and Dose Finding Study of New Vehicle Formulations Containing Ingenol Mebutate to Treat Actinic Keratosis on the Forearm

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

February 28, 2013

Primary Completion Date

October 31, 2013

Study Completion Date

December 31, 2013

Conditions
Actinic Keratosis
Interventions
DRUG

once daily for two consecutive days (Picato)

Trial Locations (2)

4102

Dermatology Department, Woolloongabba

Specialist Connect, Woolloongabba

Sponsors

Lead Sponsor

LEO Pharma
All Listed Sponsors
lead

LEO Pharma

INDUSTRY